Solugen's new funding, Ambercycle's latest deal, petrochemical problems in Australia.
Trillium's bio-based acrylonitrile, Covestro's investment in BioBTX, and Oxy's DLE deal.
Fulcrum Bioenergy’s demise, DuPont is splitting into pieces, and a standalone ethylene-to-alky unit.
A new PO process, recycling PVC, making CO2 free cement, and converting naphtha into ethane and propane.
A bio-based 1,3 propanediol expansion, less BASF in Ludwigshafen, Equinor bought into Standard Lithium, Ashland is selling its nutraceutical biz.
Origin's cap business, SK Geocentric’s better PLA process, Ex-Solvay and Orbia broke ground, and Potassium formate from CO2.
Encina isn’t going to Pennsylvania, Anellotech and Technip signed a deal, Standard Lithium started up its demo-scale DLE plant, and SK Capital sold Foremark after 7 years.
Guess who's back?
Ineos' EO acquisition, Lanxess and sulfur carriers, sustainable EO, CO2 to methanol, and Cyclyx's first plant.
Clariant's cellulosic bioethanol, reducing CO2 to CO, financing lithium, retrofitting a refinery, electrolytes, sodium sulfate, and licensing.
Waste plastic to phenol, concrete admixtures, ferric sulfate, net-zero steam cracking, Röhm and SABIC.
PureCycle's problems, OCOChem, Origin's layoff, LyondellBasell and MoReTec, LanzaTech and steel, Goodyear, and Evonik.
